Updated Aug. 12, 2014 at 7:25 a.m.

Premium Lock Wall Street Journal report questions investor confidence in GSK's CEO

Published: 2014-08-12 07:19:00
Updated: 2014-08-12 07:25:15

Andrew Witty    Andrew Witty. (GSK photo)

Another day, another headache in the global press for GlaxoSmithKline and its CEO Andrew Witty. This time it's an in-depth report in The Wall Street Journal in which some investors question Witty's performance as the drug giant fights lagging sales and scandal....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll